Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Nature|April 20, 2018
Structural basis of ligand binding modes at the neuropeptide Y Y1 receptorZhenlin Yang, Shuo Han, Max Keller, et al.
American Journal of Human Genetics|August 8, 2025
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunctionHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Nature Communications|April 14, 2025
Drugit: crowd-sourcing molecular design of non-peptidic VHL bindersThomas Scott, Christian Alan Paul Smethurst, Yvonne Westermaier, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver DiseaseHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
JCI Insight|August 26, 2025
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancerAmanda B Hesterberg, Hong Yuen Wong, Jorgen Jackson, et al.
Cancer Discovery|April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung CancerKartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Plos Computational Biology|May 5, 2020
Better together: Elements of successful scientific software development in a distributed collaborative communityJulia Koehler Leman, Brian D Weitzner, P Douglas Renfrew, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Immunity|December 23, 2023
Tissue factor binds to and inhibits interferon-α receptor 1 signalingJayakumar Manoharan, Rajiv Rana, Georg Kuenze, et al.
Biochemistry|March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen DesignClara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Pageof 44